Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:pituitary gland tumorous lesion incidence/prevalence measurement
go back to main search page
Accession:CMO:0001624 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display pituitary gland tumorous lesions at a point in time or develop pituitary gland tumorous lesions within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A tumorous lesion is one which is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors, preneoplastic lesions, and hyperplastic lesions composed of histologically normal cells. The pituitary gland is the small, oval endocrine gland attached to the base of the vertebrate brain and consisting of an anterior and posterior lobe, the secretions of which control the other endocrine glands and influence growth, metabolism, and maturation.



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        organ tumorous lesion incidence/prevalence measurement 18
          pituitary gland tumorous lesion incidence/prevalence measurement 0
            pituitary gland hyperplastic lesion incidence/prevalence measurement + 0
            pituitary tumor incidence/prevalence measurement + 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          organ tumorous lesion incidence/prevalence measurement 18
            pituitary gland tumorous lesion incidence/prevalence measurement 0
              pituitary gland hyperplastic lesion incidence/prevalence measurement + 0
              pituitary tumor incidence/prevalence measurement + 0
paths to the root